http://dbpedia.org/ontology/abstract
|
Biotie Therapies was a Finnish biotechnolo … Biotie Therapies was a Finnish biotechnology and pharmaceutics company that was acquired by Acorda Therapeutics in January 2016. The company's research and development was focused on drugs for neurodegenerative and psychiatric disorders like Parkinson's disease, Alzheimer's disease and other cognitive disorders, alcohol and drug dependence and post traumatic stress disorder, and inflammatory and fibrotic liver disease. The company's headquarters is in Turku, Western Finland, and it is listed on NASDAQ OMX Helsinki., and it is listed on NASDAQ OMX Helsinki.
, Biotie Therapies était une société finlandaise de biotechnologie et de pharmacie dont le siège social était situé à Turku en Finlande.Biotie Therapies est acquise par Acorda Therapeutics en janvier 2016.
|
http://dbpedia.org/ontology/foundingYear
|
1998
|
http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Chairman +
, http://dbpedia.org/resource/Chief_executive_officer +
|
http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Finland +
, http://dbpedia.org/resource/Turku +
|
http://dbpedia.org/ontology/numberOfEmployees
|
38
|
http://dbpedia.org/ontology/operatingIncome
|
2.56E7
|
http://dbpedia.org/ontology/revenue
|
4800000.0
|
http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Biotie_Therapies_logo.png?width=300 +
|
http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.biotie.fi/%3Fsc_lang=en +
, http://www.biotie.com +
|
http://dbpedia.org/ontology/wikiPageID
|
13280996
|
http://dbpedia.org/ontology/wikiPageLength
|
13649
|
http://dbpedia.org/ontology/wikiPageRevisionID
|
1122473508
|
http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Parkinson%27s_disease +
, http://dbpedia.org/resource/Phase_I_clinical_trials +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Finland +
, http://dbpedia.org/resource/Category:Companies_listed_on_Nasdaq_Helsinki +
, http://dbpedia.org/resource/Nepicastat +
, http://dbpedia.org/resource/Finland +
, http://dbpedia.org/resource/COPD +
, http://dbpedia.org/resource/Autoimmune_disease +
, http://dbpedia.org/resource/Inflammatory_diseases +
, http://dbpedia.org/resource/Pharmaceutics +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1998 +
, http://dbpedia.org/resource/Movement_disorder +
, http://dbpedia.org/resource/Leukocyte +
, http://dbpedia.org/resource/Rheumatoid_arthritis +
, http://dbpedia.org/resource/Fibrosis +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Finland +
, http://dbpedia.org/resource/Cognitive_disorders +
, http://dbpedia.org/resource/Cognitive_disorder +
, http://dbpedia.org/resource/White_blood_cell +
, http://dbpedia.org/resource/Agranulocytosis +
, http://dbpedia.org/resource/PTSD +
, http://dbpedia.org/resource/National_Institute_on_Drug_Abuse +
, http://dbpedia.org/resource/Alcohol_%28drug%29 +
, http://dbpedia.org/resource/Chronic_obstructive_pulmonary_disease +
, http://dbpedia.org/resource/Phases_of_clinical_research +
, http://dbpedia.org/resource/Alcohol_dependence +
, http://dbpedia.org/resource/Antibody +
, http://dbpedia.org/resource/Euro +
, http://dbpedia.org/resource/Radebeul +
, http://dbpedia.org/resource/Nitisinone +
, http://dbpedia.org/resource/Lundbeck +
, http://dbpedia.org/resource/AD +
, http://dbpedia.org/resource/Chief_executive_officer +
, http://dbpedia.org/resource/Category:1998_establishments_in_Finland +
, http://dbpedia.org/resource/Acorda_Therapeutics +
, http://dbpedia.org/resource/Alcoholism +
, http://dbpedia.org/resource/Monoclonal_antibody +
, http://dbpedia.org/resource/Alzheimer%27s_disease +
, http://dbpedia.org/resource/Ulcerative_colitis +
, http://dbpedia.org/resource/Category:Companies_formerly_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Nalmefene +
, http://dbpedia.org/resource/Category:Parkinson%27s_disease +
, http://dbpedia.org/resource/Turku +
, http://dbpedia.org/resource/Inflammation +
, http://dbpedia.org/resource/Unit_of_alcohol +
, http://dbpedia.org/resource/Western_Finland +
, http://dbpedia.org/resource/CNS_disorders +
, http://dbpedia.org/resource/UCB_%28company%29 +
, http://dbpedia.org/resource/Drug_dependence +
, http://dbpedia.org/resource/Vascular_Adhesion_Protein-1 +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1998 +
, http://dbpedia.org/resource/VAP-1 +
, http://dbpedia.org/resource/Liver_disease +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Post_traumatic_stress_disorder +
, http://dbpedia.org/resource/NASDAQ_OMX +
, http://dbpedia.org/resource/Psoriasis +
, http://dbpedia.org/resource/Chairman +
, http://dbpedia.org/resource/Public_company +
|
http://dbpedia.org/property/foundation
|
1998
|
http://dbpedia.org/property/homepage
|
http://www.biotie.com +
|
http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
http://dbpedia.org/property/keyPeople
|
Markku Jalkanen Timo Veromaa , Peter Fellner
|
http://dbpedia.org/property/location
|
http://dbpedia.org/resource/Finland +
, http://dbpedia.org/resource/Turku +
|
http://dbpedia.org/property/logo
|
File:Biotie Therapies logo.png
|
http://dbpedia.org/property/name
|
Biotie Therapies Oyj
|
http://dbpedia.org/property/numEmployees
|
38
|
http://dbpedia.org/property/revenue
|
4800000.0
|
http://dbpedia.org/property/tradedAs
|
NASDAQ:BITI
|
http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Rp +
, http://dbpedia.org/resource/Template:OMX +
, http://dbpedia.org/resource/Template:Gain +
, http://dbpedia.org/resource/Template:Reflist +
|
http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1998 +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Finland +
, http://dbpedia.org/resource/Category:Companies_listed_on_Nasdaq_Helsinki +
, http://dbpedia.org/resource/Category:Companies_formerly_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1998 +
, http://dbpedia.org/resource/Category:1998_establishments_in_Finland +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Finland +
, http://dbpedia.org/resource/Category:Parkinson%27s_disease +
|
http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Biotechnology +
|
http://www.w3.org/2004/02/skos/core#closeMatch
|
http://www.grid.ac/institutes/grid.476133.4 +
, http://www.grid.ac/institutes/grid.432164.6 +
|
http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Biotie_Therapies?oldid=1122473508&ns=0 +
|
http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Biotie_Therapies_logo.png +
|
http://xmlns.com/foaf/0.1/homepage
|
http://www.biotie.com +
|
http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Biotie_Therapies +
|
http://xmlns.com/foaf/0.1/name
|
Biotie Therapies Oyj
|
owl:sameAs |
http://yago-knowledge.org/resource/Biotie_Therapies +
, https://global.dbpedia.org/id/4YqN5 +
, http://fr.dbpedia.org/resource/Biotie_Therapies +
, http://www.wikidata.org/entity/Q4915361 +
, http://dbpedia.org/resource/Biotie_Therapies +
, http://fa.dbpedia.org/resource/%D8%A8%D8%A7%DB%8C%D9%88%D8%AA%DB%8C +
, http://rdf.freebase.com/ns/m.03c0ct1 +
, http://fi.dbpedia.org/resource/Biotie_Therapies +
|
rdf:type |
http://dbpedia.org/class/yago/WikicatPharmaceuticalCompaniesOfFinland +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/class/yago/DrugCompany108002578 +
, http://schema.org/Organization +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompanies +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://dbpedia.org/class/yago/WikicatCompaniesEstablishedIn1988 +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/class/yago/WikicatCompaniesListedOnTheHelsinkiStockExchange +
|
rdfs:comment |
Biotie Therapies was a Finnish biotechnolo … Biotie Therapies was a Finnish biotechnology and pharmaceutics company that was acquired by Acorda Therapeutics in January 2016. The company's research and development was focused on drugs for neurodegenerative and psychiatric disorders like Parkinson's disease, Alzheimer's disease and other cognitive disorders, alcohol and drug dependence and post traumatic stress disorder, and inflammatory and fibrotic liver disease. The company's headquarters is in Turku, Western Finland, and it is listed on NASDAQ OMX Helsinki., and it is listed on NASDAQ OMX Helsinki.
, Biotie Therapies était une société finlandaise de biotechnologie et de pharmacie dont le siège social était situé à Turku en Finlande.Biotie Therapies est acquise par Acorda Therapeutics en janvier 2016.
|
rdfs:label |
Biotie Therapies
|